Sangamo Therapeutics News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

06.01.17	Greenbrier Reports First Quarter Results (PR Newswire)
05.01.17	Sangamo BioSciences Announces FDA Clearance Of Investigational New Drug Application For SB-525 Gene Therapy Program For Hemophilia A (PR Newswire)
28.12.16	Biotech Stocks on Investors' Radar -- Eleven Biotherapeutics, Illumina, Sangamo Biosciences, and CytRx (PR Newswire)
06.12.16	Sangamo BioSciences Presents Hemophilia A Program Data At The 2016 American Society Of Hematology Meeting (PR Newswire)
01.12.16	Sangamo BioSciences Makes Key Leadership Appointments To Strengthen Clinical And Commercial Capabilities (PR Newswire)
30.11.16	Sangamo's Genome Editing Program for Hemoglobinopathies to Transfer to Biogen's Spin-Off Bioverativ (PR Newswire)
21.09.15	Sangamo Reports Updated Clinical Data From ZFP Therapeutic Program For HIV (RTTNews)
02.09.15	Sangamo And Shire Restructure Collaboration - Quick Facts (RTTNews)
06.12.13	Sangamo BioSciences Presents Clinical Data From SB-728-T HIV Studies (RTTNews)
15.11.13	Sangamo Announces Presentation Of Data From Alzheimer's Disease Program (RTTNews)
29.10.13	INCY's Got More Proof, AKRX Hits New High, ILMN Opens Wallet, RGLS On Watch (RTTNews)
16.10.13	Sangamo BioSciences Announces Third Quarter 2013 Conference Call and Webcast (PR Newswire)
07.10.13	Sangamo BioSciences Announces Presentation At the 2013 Stem Cell Meeting on the Mesa (PR Newswire)
04.10.13	Positive Results, Close of Public Offerings, Grants, Data Presentations and Partnerships - Research Report on Lexicon, Sangamo Biosciences, Immunomedics, NewLink Genetics, and Pacific Biosciences (PR Newswire)
23.09.13	Sangamo Announces Closing Of $74.2 Mln Public Offering Of Common Stock (RTTNews)
23.09.13	Sangamo BioSciences Announces Closing Of $74.2 Million Public Offering Of Common Stock And Exercise Of Over-Allotment Option (PR Newswire)
18.09.13	Sangamo BioSciences Prices Public Offering Of 6.10 Mln Shares At $10.58/shr (RTTNews)
17.09.13	Sangamo BioSciences Proposes Public Offering Of Common Stock (PR Newswire)
12.09.13	Sangamo BioSciences announces presentation of clinical Data Demonstrating Functional Control of Viremia in HIV-Infected Subjects treated with SB-728-T (PR Newswire)
12.09.13	Biotech Firms Receive Orphan Drug Designations, Release Clinical Data, Achieve Goals, Enter Acquisitions & Forecast Revenues - Research Report on Aegerion, Oncolytics, Merrimack, Sangamo, and PDL (PR Newswire)
27.08.13	ACUR Crushed, RGDX Loosens Purse Strings, QRxPharma's Trading Halted (RTTNews)
26.08.13	Sangamo BioSciences To Buy Ceregene (RTTNews)
26.08.13	Sangamo BioSciences to Acquire Ceregene (PR Newswire)
19.08.13	Positive Preliminary Results, R&D Investments, and Financial Results - Research Report on MannKind, Anacor, Sangamo, Stereotaxis, and Columbia Laboratories (PR Newswire)
14.08.13	Sangamo BioSciences Announces Notice Of Allowance For New Patent Application Covering Genome Modification Technology (PR Newswire)
07.08.13	Sangamo BioSciences Announces Presentation At The 2013 Wedbush Life Sciences Management Access Conference (PR Newswire)
24.07.13	Sangamo BioSciences Reports Second Quarter 2013 Financial Results (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

ABB	50.28	1.62 %	K V
UBS Group	28.48	1.42 %	K V
CieFinRichemont	122.70	1.24 %	K V
Lonza Grp	526.40	1.15 %	K V
Part Grp Hldg	1’280.00	1.11 %	K V
Sonova Hldg	300.80	-0.07 %	K V
Sika	228.10	-0.09 %	K V
Novartis	93.27	-0.12 %	K V
Nestle	76.48	-0.21 %	K V
Swisscom	508.50	-0.29 %	K V

mehr

29.11.24		Starker Wochentag in New York: NASDAQ Composite mittags im Aufwind
27.11.24		Anleger in New York halten sich zurück: NASDAQ Composite letztendlich leichter
26.11.24		Gute Stimmung in New York: Börsianer lassen NASDAQ Composite schlussendlich steigen
26.11.24		Starker Wochentag in New York: NASDAQ Composite präsentiert sich nachmittags fester
26.11.24		Pluszeichen in New York: NASDAQ Composite mittags in Grün
18.11.24		Starker Wochentag in New York: NASDAQ Composite zum Ende des Montagshandels mit Zuschlägen
18.11.24		Optimismus in New York: So steht der NASDAQ Composite aktuell
15.11.24		Schwacher Wochentag in New York: NASDAQ Composite präsentiert sich zum Start leichter

29.11.24

Starker Wochentag in New York: NASDAQ Composite mittags im Aufwind

27.11.24

Anleger in New York halten sich zurück: NASDAQ Composite letztendlich leichter

26.11.24

Gute Stimmung in New York: Börsianer lassen NASDAQ Composite schlussendlich steigen

26.11.24

Starker Wochentag in New York: NASDAQ Composite präsentiert sich nachmittags fester

26.11.24

Pluszeichen in New York: NASDAQ Composite mittags in Grün

18.11.24

Starker Wochentag in New York: NASDAQ Composite zum Ende des Montagshandels mit Zuschlägen